Table 1.

Patient characteristics at baselinea

PatientGenderCause of Renal FailureAge (yr)Weight (kg)BMI (kg/m2)[Hb] (g/L)Creatinine (mmol/L)Creatinine Clearance (ml/min)Urea (mmol/L)[K+] (mmol/L)
1MTIN66 85301490.2039134.8
2MPCKD35 92381210.2646123.9
3F PCKD41 86311360.3129185.4
4MFSHS50108321150.5223335.3
5MIgA46109321210.2747145.0
6MGN44 69221210.6413275.0
7MRVD48 76301380.2043114.6
8MRVD/CE62 72271330.3619284.9
9MLithium55110371340.2546165.0
10MReflux/RVD/stones61 75261320.3123225.1
11F Alport syndrome27 92331250.8313205.3
12MDiabetes50 47181270.1829215.5
Mean (SD)49 (11)85 (19)30 (6)129 (9)0.36 (0.20)31 (13)20 (7)5.0 (0.4)
  • a BMI, body mass index; CE, cholesterol embolism; FSHS, focal and segmental hyalinosis and sclerosis; GN, glomerulonephritis; [Hb], hemoglobin concentration; IgA, IgA glomerulonephritis; [K+], plasma potassium concentration; PCKD, polycystic kidney disease; RVD, renovascular disease; TIN, tubulointerstitial nephritis. Blood tests were taken at rest.